Beauty tech and devices sit at the intersection of beauty and consumer electronics. AOVs $100-$1,500+. FDA-cleared vs FDA-approved, YouTube authority, clinical endorsement, and the five crisis patterns that recur in the category.
FDA warning letters hit supplements, functional beverages, wellness devices. FTC Endorsement Guides target influencer programs. The wellness enforcement floor.
Boar's Head listeria. McDonald's E. coli outbreak from slivered onions. Multiple smaller incidents across packaged foods and produce. The 2024–2025 recall cycle produced different communications outcomes — and a set of repeating patterns.
Schedule III hit April 28, 2026 for medical cannabis. 280E lifted. Marketing budgets now deductible. Adult-use awaits June 29 DEA hearing.
CBD is the federally legal cannabinoid that built a multi-billion-dollar parallel market — and the FDA enforcement reality that defines how the brands inside it are allowed to communicate. The CBD satellite to the cannabis communications pillar.
Side Effects of popular supplements like Onnit's Alpha Brain might be a real concern.
FDA Closer to Zero, the 2021 House Subcommittee heavy metals report, the 2022 Abbott Similac crisis, California AB 899 — the regulatory and trust architecture for baby formula and infant nutrition in 2026. Plus EPR's 10-criterion Infant Nutrition Product Safety Communications Checklist.
FDA reputation management — how Dr Pepper Snapple, Unilever, JUUL, and Celsius handled warning letters, and what their cases teach modern brands.
Kellogg's June 2010 voluntary recall of 28 million cereal boxes \u2014 the canonical voluntary recall communications case study. What worked, what didn't, and how the discipline has changed.
The 2008-2009 Peanut Corporation of America salmonella outbreak — the canonical F&B food safety crisis case. 9 deaths, 700+ illnesses, 3,900+ product recalls, criminal convictions, and the regulatory restructuring that produced FSMA.
